Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,273 | -16,451 | -19,557 | -8,280 | -3,050 |
| Depreciation Amortization | 32 | 17 | 15 | 10 | 3 |
| Other Working Capital | -1,356 | -1,357 | 5,570 | 1,210 | -180 |
| Other Operating Activity | 12,979 | 460 | 503 | 600 | 837 |
| Operating Cash Flow | $-10,618 | $-17,332 | $-13,468 | $-6,460 | $-2,390 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -49 | -24 | -10 | -20 |
| Other Investing Activity | 0 | 1,185 | 466 | -1,430 | -230 |
| Investing Cash Flow | $-18 | $1,136 | $442 | $-1,440 | $-250 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,939 | 2,988 | 0 | N/A | N/A |
| Dividend Paid | N/A | -740 | -824 | -260 | 0 |
| Other Financing Activity | 9,205 | 5,470 | 13,653 | 13,840 | 6,900 |
| Financing Cash Flow | $18,143 | $7,717 | $12,830 | $13,580 | $6,900 |
| Beginning Cash Position | 1,263 | 9,742 | 9,938 | 4,260 | 10 |
| End Cash Position | 8,770 | 1,263 | 9,742 | 9,930 | 4,260 |
| Net Cash Flow | $7,507 | $-8,479 | $-197 | $5,670 | $4,250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,618 | -17,332 | -13,468 | -6,460 | -2,390 |
| Capital Expenditure | -18 | -49 | -24 | N/A | N/A |
| Free Cash Flow | -10,636 | -17,381 | -13,493 | -6,460 | -2,390 |